Alovudine 18F Injection and its Impurities

Alovudine F-18 is under investigation in clinical trial NCT02819024. Dexamethasone Effects in Patients With Refractory Non-Small Cell Lung Cancer Using FLT Positron Emission Tomography. Reference standards of Alovudine 18F Injection API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 3 results for Alovudine 18F Injection Impurities
PA 01 4010000

Alovudine (18F) Injection

Alovudine (18F) Injection

  • Catalogue No.:PA 01 4010000

  • CAS :

    287114-80-1

  • Molecular Formula : C10H1318FN2O4

  • Molecular Weight : 243.22

Enquire
Details
PA 01 4010050

Alovudine (18F) Injection - Impurity E

tert-Butyl 3-[(2R,4R,5R)-5-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-4-[[(4-nitrophenyl)sulfonyl]oxy]tetrahydrofuran-2-yl]-5-methyl-2,6-dioxo-3,6-dihydropyrimidine-1(2H)-carboxylate

  • Catalogue No.:PA 01 4010050

  • CAS :

    444717-23-1

  • Molecular Formula : C42H43N3O13S

  • Molecular Weight : 829.87

Enquire
Details
PA 01 4010060

Alovudine (18F) Injection - Impurity F

(2R,3R,5R)-3-[[Bis(4-methoxyphenyl)phenylmethoxy]-methyl]-8-methyl-2,3-dihydro-9H-2,5-methanopyrimido-[2,1-b][1,5,3]dioxazepin-9-one

  • Catalogue No.:PA 01 4010060

  • CAS :

    191474-13-2

  • Molecular Formula : C31H30N2O6

  • Molecular Weight : 526.59

Enquire
Details
Periodic Table- Pharmaffiliates

Calculators
Periodic Table- Pharmaffiliates

Contact us

Ask A Scientist-Pharmaffiliates

Ask a Scientist
General Help

General Help
CPHI INDIA- 28, 30 November